Sanofi and GSK are pleased to announce that they have signed a letter of intent...
Sanofi CEPiA has announced that the company will now be known as Sanofi Active Ingredient Solutions.
The new name clearly states that CEPiA is part of Sanofi. It also describes the company’s core activity (active ingredients) and reflects on its teams’ dedication for working with customers to find tailored solutions meeting their specific needs.
Did you know that Sanofi Active Ingredient Solutions comprises more than 2,000 women and men working passionately every day to develop, manufacture and supply active pharmaceutical ingredients (API) and technical solutions for the markets across the world?
Its name is changing, but not its work standards. The company will continue to serve its customers and work closely with them with the same permanent focus on satisfaction and success. The firm’s commitment is based on the following pillars:
- Reliability of a global leader in biopharmacy
- High-quality services
- Business continuity
- Premium customer service
To do so, Sanofi Active Ingredient Solutions works with passion, pride and rigour, recognising that its products are the key contributor to therapeutic solutions, helping millions of people live life to its full potential, every day, all over the world.
Sanofi Active Ingredient Solutions is at the heart of Sanofi’s mission of being a health journey partner.
Sanofi and Regeneron Provide Update on US Phase 2/3 Adaptive-Designed Trial in Hospitalised Covid-19 Patients
Sanofi and Regeneron Pharmaceuticals have announced the preliminary results from the Phase 2 portion of...
Sanofi Active Ingredient Solutions have more than 2,000 people developing, manufacturing and supplying active pharmaceutical...